EFX

Understanding EFX's Price Drop Today

Equifax plummeted to $246.44 per share this evening, but it remains 10.02% above its mean target price of $224.0. There may still be room for more downwards movement — even after today's -1.1% drop. Analysts are giving the large-cap Diversified Financial stock on average rating of buy, with target prices ranging from $164.0 to $315.0 per share.

Equifax's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 3.4%. The stock's short ratio is 4.4. The company's insiders own 0.39% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.

Another number to watch is the company's rate of institutional share ownership, which now stands at 98.1%. In conclusion, we believe there is mixed market sentiment regarding Equifax.

Institutions Invested in Equifax

Date Reported Holder Percentage Shares Value
2023-09-30 Vanguard Group Inc 11% 13,691,006 $3,374,011,552
2023-09-30 Capital International Investors 11% 13,662,586 $3,367,007,727
2023-09-30 Blackrock Inc. 8% 9,937,502 $2,448,998,017
2023-09-30 T. Rowe Price Investment Management, Inc. 6% 7,152,122 $1,762,568,963
2023-09-30 Massachusetts Financial Services Co. 5% 6,210,384 $1,530,487,048
2023-09-30 Morgan Stanley 4% 4,989,226 $1,229,544,867
2023-09-30 State Street Corporation 4% 4,574,165 $1,127,257,233
2023-09-30 Generation Investment Management LLP 3% 3,557,402 $876,686,157
2023-09-30 Geode Capital Management, LLC 2% 2,631,903 $648,606,181
2023-09-30 Invesco Ltd. 2% 2,591,853 $638,736,259
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS